Getein Biotech, Inc

¥8.51As of Sun 8 Nov 2026, 12:00 UTC
SSE:603387Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (2.45%)
Div yield 3.52%
ROE 10.07%
Medical Devices
Beta (5Y) 0.08
PE TTM 14.67
TSR TTM 5.76%
Mkt cap ¥4.310B
ROIC 15.68%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥11
26.61%
(72.70%)
Hold 10|11|8|3|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.11
0.11
0.11
0.11
32.16%
24.94%
11.58%
1.60%
Revenue¥M
226.1
225.8
236.5
241.9
5.02%
7.38%
12.87%
13.39%
Peers (US$646.0M)
Cap (US$)
PE
654.9M
12.11x
Capital
TTM
5Y
10Y
Leveragex
0.287
0.028
0.029
EBIT/Intx
1.904
0.063
0.072
Own earn%
242.99
(35.53)
(22.27)
Sh yield%
53.80
24.72
30.02
Owners
Insiders/Inst%
0.60
41.28
Short interest%
3.38
SBC / revenue%
3.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
18–23
$1 testx
−0.1
Incr. ROIC%
1